Ridgeback Capital Management, based in Miami Beach, is a prominent investment firm led by Wayne Holman. Specializing in healthcare and biotechnology sectors, Ridgeback Capital Investments focuses on companies such as Adaptimmune, Celgene, and Gilead among others.
With a strategic focus on cutting-edge medical advancements, Ridgeback Capital Management actively invests in companies like Intercept, Regeneron, and Vertex to drive innovation and growth in the healthcare industry.
Generated from their website's infomation